MRK Financial Facts
Total Costs, Expenses and Other: 12.82BSales: 23.64B
See Full Income Statement
Accrued and other current liabilities: 5.48B
Other Assets: 5.15B
See Full Balance Sheet
Merck & Co. Inc. (MRK) Earnings
|
Expand Research on MRK
| Next EPS Date | 7/30/24 *Est. | EPS Growth Rate | +47.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +37.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/1/23 | Q223 | -$2.06 | -$2.18 | +$0.12 | $15B | $14.43B | = |  | | Details | |
| 2/1/24 | Q423 | $0.03 | -$0.11 | +$0.14 | $14.6B | $14.47B | = | | | Details | |
4/28/15  |
 |
Q115 | $0.85 | $0.74 | +$0.11 | $9.4B | $9.04B |  |
| | Details |
| 5/1/13 |
|
Q113 | $0.85 | $0.79 | +$0.06 | $10.7M | $11.09M | = | | | Details |
| 4/29/14 |
|
Q114 | $0.88 | $0.79 | +$0.09 | $10.3B | $10.44B | = | | | Details |
| 7/29/14 |
|
Q214 | $0.85 | $0.80 | +$0.05 | $10.93B | $10.6B | = | | | Details |
| 7/28/15 |
|
Q215 | $0.86 | $0.81 | +$0.05 | $9.8B | $9.8B | |
| | Details |
| 2/1/13 |
|
Q412 | $0.83 | $0.81 | +$0.02 | $11.7B | $11.46B | = | | | Details |
